Pandemic preparedness of effective vaccines for the outbreak of newly H5N1 highly pathogenic avian influenza virus
- PMID: 39622294
- PMCID: PMC11738761
- DOI: 10.1016/j.virs.2024.11.005
Pandemic preparedness of effective vaccines for the outbreak of newly H5N1 highly pathogenic avian influenza virus
Abstract
- •
Analyzed the outbreak situation and viral characteristics of the newly H5N1 highly pathogenic avian influenza (HPAI) virus.
- •
The current approval and research and development of the H5N1 HPAI vaccines were summarized.
- •
Proposed vaccine development approaches against newly H5N1 virus, e.g. adjuvanted vaccine, mRNA vaccine, multivalent vaccine.
- •
Discussed other prevention and control strategies, e.g. poultry vaccination, global surveillance and comprehensive testing.
Figures
References
-
- Fan S., Deng G., Song J., Tian G., Suo Y., Jiang Y., Guan Y., Bu Z., Kawaoka Y., Chen H. Two amino acid residues in the 253 matrix protein m1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology. 2009;384:28–32. - PubMed
-
- Furey C., Scher G., Ye N., Kercher L., Debeauchamp J., Crumpton J.C., Jeevan T., Patton C., Franks J., Rubrum A., Alameh M., Fan S.H.Y., Phan A.T., Hunter C.A., Webby R.J., Weissman D., Hensley S.E. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus. Nat. Commun. 2024;15:4350. - PMC - PubMed
LinkOut - more resources
Full Text Sources
